GUTS (fractyl.com) Bozor qiymatining balans qiymatiga nisbati

Fractyl Health Inc. (GUTS) kompaniyasining rasmiy ramzlari

GURU.Markets platformasidagi Fractyl Health, Inc. (GUTS) narxlar grafigi aktivning dinamikasini ko'rsatadi, u hozirda -6.83 miqdorida baholanmoqda. Metabolik buzilishlar uchun innovatsion terapiya tizimlarini ishlab chiqish hozirda katta investitsiyalarni talab qilmoqda, bu esa vaqtincha laboratoriya xarajatlarini oshirmoqda. Biznes saxovatli aksiyalar opsionlari bilan jalb qilingan yetakchi diabetologlar xodimlariga tayanadi. Shu bilan birga, Fractyl Health, Inc. (GUTS) davolashga bo'lgan talab iqtisodiy sikllardan mustaqil bo'lib qolgan himoyalangan nishda faoliyat yuritmoqda.

GUTS Fractyl Health, Inc: Balans qiymatiga nisbatan bozor qiymati 21.02.2024 - 28.10.2026 oraligʻida
Fractyl original mahsuloti

Fractyl Health, Inc. o'zining innovatsion platformasini ishlab chiqish uchun yetakchi biologlar va tadqiqotchilarni jalb qilishga e'tibor qaratadi. Bozor kapitalizatsiyasining buxgalteriya qiymatiga nisbati emitentning sof aktivlaridan yuqori bo'lgan bozor qiymati premiumini o'lchaydi. -6.83 ning joriy qiymati investorlarning kompaniyaning kelgusidagi yutuqlari bo'yicha kutganlarini aks ettiradi. Sanoat normalaridan oshib ketish, korreksiya xavfi ortishi bilan birga potentsial daromadlar haqida signal beradi. Kompaniyaning P/BV grafigidagi narx harakati choraklik hisobotlarni kutmasdan real vaqt rejimida solishtirish imkonini beradi.

Asosiy raqobatchilar

Ascendis Pharma A/S - Bozor qiymatining balans qiymatiga nisbati|MDGL (madrigalpharma.com) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Corcept Therapeutics Incorporated CORT|Sof aktivlarga nisbatan bozor kapitallashuvi Rhythm Pharma|Akero Therapeutics Inc (AKRO) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Metsera Therapeutics (MTSR)|Bozor kapitallashuvining balans qiymatiga nisbati MLTX (MoonLake Immunotherapeutics)|crinetics.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati NewAmsterdam Pharma Company N.V. (NAMS)|SLNO: Balans qiymatiga nisbatan bozor qiymati|FOLD (Amicus Pharma) - Bozor qiymatining balans qiymatiga nisbati|89bio Pharma (ETNB) - Kapitallashuvning sof aktivlarga nisbati|AGIO (Agios Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati structuretx.com (GPCR)|MiMedx (MDXG) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati RZLT (Rezolute Inc)|Lexicon Pharma - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati MBX Corp MBX|ALT (Altimmune, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|aardvarktherapeutics.com (AARD) - Bozor qiymatining balans qiymatiga koeffitsiyenti|SGMT - Kapitallashuvning sof aktivlarga nisbati|BioAge Labs (BIOA) - Bozor kapitallashuvining balans qiymatiga multiplikatori|BMEA (Biomea) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Quince|Bozor kapitallashuvining balans qiymatiga nisbati vTv Therapeutics Inc. (VTVT)|Bozor qiymatining balans qiymatiga nisbati ATPC (agapeatpgroup.com)|PLUR: Bozor qiymatining balans qiymatiga nisbati|Synlogic Inc. - Bozor qiymatining balans qiymatiga koeffitsiyenti|LPCN - Bozor qiymatining balans qiymatiga nisbati|MTNB - Bozor qiymatining balans qiymatiga nisbati|Spruce Biosciences - Bozor kapitallashuvining balans qiymatiga nisbati|GLTO (galecto.com) - Balans qiymatiga nisbatan bozor kapitallashuvi|CTCX: Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi LUMO|Bozor qiymatining balans qiymatiga nisbati ONVO (Organovo Holdings Inc)|Kapitallashuvning sof aktivlarga nisbati Radius Pharmaceuticals (RDUS)